Psychoactive substances regulation

Psychoactive substances are regulated in New Zealand by the Psychoactive Substances Act 2013. The aim of the Act is to protect the health of, and minimise harm to, individuals who use psychoactive substances. The Psychoactive Substances Regulatory Authority administers the Act.

Synthetic cannabis

In July 2018, the Coroner advised that since 1 June 2017 there were 40 to 45 deaths across New Zealand which provisionally appear to be attributable to synthetic cannabis toxicity. Agencies are working together to address how best to reduce the harms from synthetic cannabinoids. Read more

Psychoactive Substances Act 2013

The Act aims to regulate the availability of psychoactive substances in New Zealand to protect the health of, and minimise harm to, individuals who use psychoactive substances. Read more

How to get a product approved

Information for applicants submitting a product approval application. Read more

  • The Code of Manufacturing Practice outlines the quality control requirements for manufacturers of psychoactive substances.
  • Register of Product Approvals - Note: There are no approved products and no applications for a product have been received.

How to get a licence

Find out about the cost of and how to apply for a licence to import, research, manufacture, wholesale, retail, sell unapproved substances. Read more

Information for healthcare professionals

Information about the Unidentified Substance in Emergency Departments (USED) Programme, clinical advice, guidance and forms, and clinical coding for synthetic cannabis. Read more

Psychoactive Substances Expert Advisory Committee

The Psychoactive Substances Expert Advisory Committee provides technical advice to the Authority. Read more.

The Psychoactive Substances Appeals Committee

The Psychoactive Substances Appeals Committee (PSAC) hears appeals against decisions made by the Psychoactive Substances Regulatory Authority. Read more

Back to top